<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03300895</url>
  </required_header>
  <id_info>
    <org_study_id>HIIT2-AFIS-UdeA</org_study_id>
    <nct_id>NCT03300895</nct_id>
  </id_info>
  <brief_title>High-intensity Interval Training on Cardiorespiratory Fitness in Overweight Women</brief_title>
  <official_title>Effect of Low-volume High-intensity Interval Training on Cardiorespiratory Fitness and Total Body Fat in Overweight Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad de Antioquia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidad de Antioquia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      High-intensity interval training (HIIT) is currently considered one of the most effective&#xD;
      strategies to improved cardiorespiratory fitness, which is recognized as a protective factor&#xD;
      for cardiovascular diseases and metabolic diseases such as overweight and obesity. However,&#xD;
      current evidence is still limited and requires clarity (frequency, time per session and&#xD;
      intensity) regarding to greater increases attributed to HIIT.&#xD;
&#xD;
      The aim of this study is to compare the effect of a low-volume high-intensity interval&#xD;
      training versus a moderate-intensity continuous exercise on maximal oxygen consumption in&#xD;
      overweight women 18 to 44 years old.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Thirty-six women will be randomly assigned to one of two aerobic exercise on a real-life&#xD;
      setting supervised for a physical activity instructor. The interventions will performed three&#xD;
      times a week for ten-weeks (on alternate days).&#xD;
&#xD;
      The first two weeks will correspond to the conditioning period (30 minutes between 55-65% of&#xD;
      maximum heart rate (HRmax). From week three, 18 participants will perform 30 minutes of&#xD;
      continuous exercise at an intensity between 65-75 % of HRmax, and the remaining 18 will&#xD;
      complete 21.5 minutes of interval exercise at an intensity between 90-95% of HRmax, with&#xD;
      recoveries between 50-55% of HRmax.&#xD;
&#xD;
      All Participants will be evaluated to measure their maximal oxygen consumption, total body&#xD;
      fat, waist circumference, body mass index, systolic blood pressure, diastolic blood pressure,&#xD;
      prior to start the interventions and at the end of the program (week 11).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 14, 2017</start_date>
  <completion_date type="Actual">November 30, 2018</completion_date>
  <primary_completion_date type="Actual">November 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in maximal oxygen consumption</measure>
    <time_frame>Baseline and after 10 weeks</time_frame>
    <description>Maximal oxygen consumption will be obtained using a graded exercise test on a treadmill (Trackmaster® model TMX 425C) using a portable K4b2 gas analyzer (Cosmed Inc., IL, USA)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in total body fat</measure>
    <time_frame>Baseline and after 10 weeks</time_frame>
    <description>Total body fat will be obtained using an Omron® HBF-510 (Omron Healthcare, Inc. Bannockburn, IL, USA) bioelectrical impedance machine.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">35</enrollment>
  <condition>Healthy Volunteers</condition>
  <arm_group>
    <arm_group_label>High-intensity interval training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Moderate-intensity continuous exercise</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High-intensity interval training</intervention_name>
    <description>21.5 minutes of high-intensity interval exercise at an intensity between 90-95 of HRmax (15x30 s), with recoveries at 50-60% of HRmax (14x60 s). 24 sessions, 3x weekly of walking and running outdoors on a sports field in a supervised manner.</description>
    <arm_group_label>High-intensity interval training</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Comparator: Moderate-intensity continuous exercise</intervention_name>
    <description>30 minutes of continuous exercise at an intensity between 65-75% of HRmax. 24 sessions, 3x weekly of walking and jogging outdoors on a sports field in a supervised manner</description>
    <arm_group_label>Moderate-intensity continuous exercise</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Overweight (≥ 25 kg/m-2) women 18 to 44 years.&#xD;
&#xD;
          -  Healthy volunteers.&#xD;
&#xD;
          -  Perform ≤ 600 Met/min/week.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Perform high-intensity interval exercise in the last six month.&#xD;
&#xD;
          -  Smoker.&#xD;
&#xD;
          -  History of asthma.&#xD;
&#xD;
          -  History of diabetes.&#xD;
&#xD;
          -  History of hypertension.&#xD;
&#xD;
          -  History of cardiovascular disease.&#xD;
&#xD;
          -  History of coronary heart disease.&#xD;
&#xD;
          -  Arrhythmias.&#xD;
&#xD;
          -  Personal history of surgical procedures in the last three months&#xD;
&#xD;
          -  Uncontrolled non-communicable diseases&#xD;
&#xD;
          -  Under medical treatment with anticoagulants, beta-blockers, calcium antagonists,&#xD;
             bronchodilators, and/or steroids.&#xD;
&#xD;
          -  Psychological, neuromotor and/or osteo-muscular conditions that may affect&#xD;
             participation in an exercise program.&#xD;
&#xD;
          -  Psychoactive drug abuse.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>44 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Universidad de Antioquia</name>
      <address>
        <city>Medellín</city>
        <state>Antioquia</state>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Colombia</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>September 28, 2017</study_first_submitted>
  <study_first_submitted_qc>October 2, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 4, 2017</study_first_posted>
  <last_update_submitted>February 1, 2019</last_update_submitted>
  <last_update_submitted_qc>February 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad de Antioquia</investigator_affiliation>
    <investigator_full_name>Victor Hugo Arboleda Serna</investigator_full_name>
    <investigator_title>PhD, MSc</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

